Corporate Action22 Sept 2026, 11:14 am
Ind-Swift Labs: Promoter Group Acquires 70 Lakh Warrants
AI Summary
Essix Biosciences Limited, along with other promoter group members, has acquired 70,00,000 Fully Convertible Warrants in Ind-Swift Laboratories Limited on a preferential basis. These warrants are convertible into an equivalent number of equity shares. This acquisition, disclosed under SEBI's takeover regulations, signifies a strengthening of the promoter group's stake and potential future equity in the target company. The transaction occurred on September 17, 2026, with the disclosure made on September 21, 2026.
Key Highlights
- Promoter group acquired 70 lakh convertible warrants in Ind-Swift Labs.
- Acquisition was made on a preferential basis.
- Warrants are convertible into equity shares.
- Disclosure made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
- Transaction strengthens promoter group's potential equity holding.
Price Impact
More from INDSWFTLAB